Internal Medicine, Nephrology · Philadelphia, PA
NPI
1265532923
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
235 N Broad St, Suite 200 Clinical Nephrology Assoc
Philadelphia, PA, 19107
Phone (215) 762-7785
Groups this clinician bills Medicare through
Medicare paid, 2024
$164K
1,642 services
Medicare patients, 2024
203
Average age 67
Drug cost, 2024
$340K
2,270 prescriptions
Company payments, 2025
$5,273
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Larry E Krevolin was code 99232 (hospital e&m - subsequent), 468 times for 75 patients. In total Larry E Krevolin billed 1,642 services in 20 codes, and Medicare paid $164K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-12-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 468 | 75 | $64.39 | $30K |
| 90960 ESRD Related Services (not dialysis) | Office | 250 | 39 | $273.82 | $68K |
| 99214 Office E&M - Established | Office | 187 | 82 | $92.20 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 180 | 88 | $13.13 | $2,363 |
| 99233 Hospital E&M - Subsequent | Facility | 93 | 23 | $96.90 | $9,012 |
| 99223 Hospital E&M - Initial | Facility | 71 | 60 | $139.78 | $9,925 |
| 90966 ESRD Related Services (not dialysis) | Office | 49 | 11 | $231.92 | $11K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 42 | 12 | $50.38 | $2,116 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 29 | 12 | $39.93 | $1,158 |
| 99222 Hospital E&M - Initial | Facility | 14 | 12 | $106.97 | $1,498 |
By year: 2022 $188K for 1,137 services; 2023 $179K for 1,408 services; 2024 $164K for 1,642 services.
Medicare prescription drug claims, 2024
In 2024, the drug Larry E Krevolin prescribed most often to Medicare patients was Chlorthalidone, with 121 prescriptions and refills. In total Larry E Krevolin wrote 2,270 Medicare prescriptions that cost $340K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Chlorthalidone Generic | 121 | 251 | 39 | $1,181 |
| Amlodipine Besylate Generic | 99 | 210 | 31 | $423 |
| Sevelamer Carbonate Generic | 93 | 155 | 28 | $16K |
| Alprazolam Generic | 93 | 93 | 11 | $386 |
| Furosemide Generic | 83 | 158 | 23 | $309 |
| Calcium Acetate Generic | 70 | 88 | 17 | $4,374 |
| Spironolactone Generic | 61 | 115 | 17 | $562 |
| Carvedilol Generic | 58 | 142 | 22 | $552 |
| Losartan Potassium Generic | 57 | 110 | 18 | $584 |
| Clonidine Generic | 48 | 86 | Under 11 | $4,916 |
| Olmesartan Medoxomil Generic | 47 | 81 | Under 11 | $853 |
| Calcitriol Generic | 47 | 93 | 13 | $663 |
| Allopurinol Generic | 43 | 85 | 16 | $461 |
| Valsartan Generic | 43 | 100 | 16 | $1,213 |
| Metoprolol Tartrate Generic | 41 | 77 | 16 | $296 |
Brand drugs: 290 claims; generic drugs: 1,929 claims; opioid claims: 61.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Larry E Krevolin $5,273 ($5,273 in general payments such as food, travel and fees) from 15 companies. The largest payer was Otsuka Pharmaceutical Development & Commercialization, Inc. with $4,065.
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 5 | $4,065 |
| Novo Nordisk Inc NVO | 9 | $338 |
| OPKO Pharmaceuticals, LLC | 20 | $172 |
| Travere Therapeutics, Inc. TVTX | 6 | $151 |
| Ardelyx, Inc. ARDX | 4 | $90.96 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $85.58 |
| Calliditas Therapeutics US Inc. | 3 | $80.08 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $59.45 |
| Amgen Inc. AMGN | 3 | $58.29 |
| Lilly USA, LLC LLY | 2 | $40.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.